1 Market Overview 1.1 Sunitinib Malate (CAS 341031-54-7) Introduction 1.2 Market Analysis by Type 1.2.1 Overview: Global Sunitinib Malate (CAS 341031-54-7) Revenue by Type: 2017 Versus 2021 Versus 2028 1.2.2 Purity Above 99% 1.2.3 Purity Above 98% 1.2.4 Purity Above 97% 1.3 Market Analysis by Application 1.3.1 Overview: Global Sunitinib Malate (CAS 341031-54-7) Revenue by Application: 2017 Versus 2021 Versus 2028 1.3.2 Advanced Kidney Cancer 1.3.3 GIST (Gastrointestinal Stromal Tumor) 1.3.4 Pancreatic Neuroendocrine Tumors 1.4 Global Sunitinib Malate (CAS 341031-54-7) Market Size & Forecast 1.4.1 Global Sunitinib Malate (CAS 341031-54-7) Sales in Value (2017 & 2021 & 2028) 1.4.2 Global Sunitinib Malate (CAS 341031-54-7) Sales in Volume (2017-2028) 1.4.3 Global Sunitinib Malate (CAS 341031-54-7) Price (2017-2028) 1.5 Global Sunitinib Malate (CAS 341031-54-7) Production Capacity Analysis 1.5.1 Global Sunitinib Malate (CAS 341031-54-7) Total Production Capacity (2017-2028) 1.5.2 Global Sunitinib Malate (CAS 341031-54-7) Production Capacity by Geographic Region 1.6 Market Drivers, Restraints and Trends 1.6.1 Sunitinib Malate (CAS 341031-54-7) Market Drivers 1.6.2 Sunitinib Malate (CAS 341031-54-7) Market Restraints 1.6.3 Sunitinib Malate (CAS 341031-54-7) Trends Analysis 2 Manufacturers Profiles 2.1 Pfizer Sutent 2.1.1 Pfizer Sutent Details 2.1.2 Pfizer Sutent Major Business 2.1.3 Pfizer Sutent Sunitinib Malate (CAS 341031-54-7) Product and Services 2.1.4 Pfizer Sutent Sunitinib Malate (CAS 341031-54-7) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.2 Topcare pharmaceutical Co., Ltd 2.2.1 Topcare pharmaceutical Co., Ltd Details 2.2.2 Topcare pharmaceutical Co., Ltd Major Business 2.2.3 Topcare pharmaceutical Co., Ltd Sunitinib Malate (CAS 341031-54-7) Product and Services 2.2.4 Topcare pharmaceutical Co., Ltd Sunitinib Malate (CAS 341031-54-7) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.3 Nanjing First Pharmaceutical Co., Ltd. 2.3.1 Nanjing First Pharmaceutical Co., Ltd. Details 2.3.2 Nanjing First Pharmaceutical Co., Ltd. Major Business 2.3.3 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate (CAS 341031-54-7) Product and Services 2.3.4 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate (CAS 341031-54-7) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.4 J&K Scientific 2.4.1 J&K Scientific Details 2.4.2 J&K Scientific Major Business 2.4.3 J&K Scientific Sunitinib Malate (CAS 341031-54-7) Product and Services 2.4.4 J&K Scientific Sunitinib Malate (CAS 341031-54-7) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.5 Target Molecule Corp. 2.5.1 Target Molecule Corp. Details 2.5.2 Target Molecule Corp. Major Business 2.5.3 Target Molecule Corp. Sunitinib Malate (CAS 341031-54-7) Product and Services 2.5.4 Target Molecule Corp. Sunitinib Malate (CAS 341031-54-7) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 3 Sunitinib Malate (CAS 341031-54-7) Breakdown Data by Manufacturer 3.1 Global Sunitinib Malate (CAS 341031-54-7) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022) 3.2 Global Sunitinib Malate (CAS 341031-54-7) Revenue by Manufacturer (2019, 2020, 2021, and 2022) 3.3 Key Manufacturer Market Position in Sunitinib Malate (CAS 341031-54-7) 3.4 Market Concentration Rate 3.4.1 Top 3 Sunitinib Malate (CAS 341031-54-7) Manufacturer Market Share in 2021 3.4.2 Top 6 Sunitinib Malate (CAS 341031-54-7) Manufacturer Market Share in 2021 3.5 Global Sunitinib Malate (CAS 341031-54-7) Production Capacity by Company: 2021 VS 2022 3.6 Manufacturer by Geography: Head Office and Sunitinib Malate (CAS 341031-54-7) Production Site 3.7 New Entrant and Capacity Expansion Plans 3.8 Mergers & Acquisitions 4 Market Analysis by Region 4.1 Global Sunitinib Malate (CAS 341031-54-7) Market Size by Region 4.1.1 Global Sunitinib Malate (CAS 341031-54-7) Sales in Volume by Region (2017-2028) 4.1.2 Global Sunitinib Malate (CAS 341031-54-7) Revenue by Region (2017-2028) 4.2 North America Sunitinib Malate (CAS 341031-54-7) Revenue (2017-2028) 4.3 Europe Sunitinib Malate (CAS 341031-54-7) Revenue (2017-2028) 4.4 Asia-Pacific Sunitinib Malate (CAS 341031-54-7) Revenue (2017-2028) 4.5 South America Sunitinib Malate (CAS 341031-54-7) Revenue (2017-2028) 4.6 Middle East and Africa Sunitinib Malate (CAS 341031-54-7) Revenue (2017-2028) 5 Market Segment by Type 5.1 Global Sunitinib Malate (CAS 341031-54-7) Sales in Volume by Type (2017-2028) 5.2 Global Sunitinib Malate (CAS 341031-54-7) Revenue by Type (2017-2028) 5.3 Global Sunitinib Malate (CAS 341031-54-7) Price by Type (2017-2028) 6 Market Segment by Application 6.1 Global Sunitinib Malate (CAS 341031-54-7) Sales in Volume by Application (2017-2028) 6.2 Global Sunitinib Malate (CAS 341031-54-7) Revenue by Application (2017-2028) 6.3 Global Sunitinib Malate (CAS 341031-54-7) Price by Application (2017-2028) 7 North America by Country, by Type, and by Application 7.1 North America Sunitinib Malate (CAS 341031-54-7) Sales by Type (2017-2028) 7.2 North America Sunitinib Malate (CAS 341031-54-7) Sales by Application (2017-2028) 7.3 North America Sunitinib Malate (CAS 341031-54-7) Market Size by Country 7.3.1 North America Sunitinib Malate (CAS 341031-54-7) Sales in Volume by Country (2017-2028) 7.3.2 North America Sunitinib Malate (CAS 341031-54-7) Revenue by Country (2017-2028) 7.3.3 United States Market Size and Forecast (2017-2028) 7.3.4 Canada Market Size and Forecast (2017-2028) 7.3.5 Mexico Market Size and Forecast (2017-2028) 8 Europe by Country, by Type, and by Application 8.1 Europe Sunitinib Malate (CAS 341031-54-7) Sales by Type (2017-2028) 8.2 Europe Sunitinib Malate (CAS 341031-54-7) Sales by Application (2017-2028) 8.3 Europe Sunitinib Malate (CAS 341031-54-7) Market Size by Country 8.3.1 Europe Sunitinib Malate (CAS 341031-54-7) Sales in Volume by Country (2017-2028) 8.3.2 Europe Sunitinib Malate (CAS 341031-54-7) Revenue by Country (2017-2028) 8.3.3 Germany Market Size and Forecast (2017-2028) 8.3.4 France Market Size and Forecast (2017-2028) 8.3.5 United Kingdom Market Size and Forecast (2017-2028) 8.3.6 Russia Market Size and Forecast (2017-2028) 8.3.7 Italy Market Size and Forecast (2017-2028) 9 Asia-Pacific by Region, by Type, and by Application 9.1 Asia-Pacific Sunitinib Malate (CAS 341031-54-7) Sales by Type (2017-2028) 9.2 Asia-Pacific Sunitinib Malate (CAS 341031-54-7) Sales by Application (2017-2028) 9.3 Asia-Pacific Sunitinib Malate (CAS 341031-54-7) Market Size by Region 9.3.1 Asia-Pacific Sunitinib Malate (CAS 341031-54-7) Sales in Volume by Region (2017-2028) 9.3.2 Asia-Pacific Sunitinib Malate (CAS 341031-54-7) Revenue by Region (2017-2028) 9.3.3 China Market Size and Forecast (2017-2028) 9.3.4 Japan Market Size and Forecast (2017-2028) 9.3.5 Korea Market Size and Forecast (2017-2028) 9.3.6 India Market Size and Forecast (2017-2028) 9.3.7 Southeast Asia Market Size and Forecast (2017-2028) 9.3.8 Australia Market Size and Forecast (2017-2028) 10 South America by Region, by Type, and by Application 10.1 South America Sunitinib Malate (CAS 341031-54-7) Sales by Type (2017-2028) 10.2 South America Sunitinib Malate (CAS 341031-54-7) Sales by Application (2017-2028) 10.3 South America Sunitinib Malate (CAS 341031-54-7) Market Size by Country 10.3.1 South America Sunitinib Malate (CAS 341031-54-7) Sales in Volume by Country (2017-2028) 10.3.2 South America Sunitinib Malate (CAS 341031-54-7) Revenue by Country (2017-2028) 10.3.3 Brazil Market Size and Forecast (2017-2028) 10.3.4 Argentina Market Size and Forecast (2017-2028) 11 Middle East & Africa by Country, by Type, and by Application 11.1 Middle East & Africa Sunitinib Malate (CAS 341031-54-7) Sales by Type (2017-2028) 11.2 Middle East & Africa Sunitinib Malate (CAS 341031-54-7) Sales by Application (2017-2028) 11.3 Middle East & Africa Sunitinib Malate (CAS 341031-54-7) Market Size by Country 11.3.1 Middle East & Africa Sunitinib Malate (CAS 341031-54-7) Sales in Volume by Country (2017-2028) 11.3.2 Middle East & Africa Sunitinib Malate (CAS 341031-54-7) Revenue by Country (2017-2028) 11.3.3 Turkey Market Size and Forecast (2017-2028) 11.3.4 Egypt Market Size and Forecast (2017-2028) 11.3.5 Saudi Arabia Market Size and Forecast (2017-2028) 11.3.6 South Africa Market Size and Forecast (2017-2028) 12 Raw Material and Industry Chain 12.1 Raw Material of Sunitinib Malate (CAS 341031-54-7) and Key Manufacturers 12.2 Manufacturing Costs Percentage of Sunitinib Malate (CAS 341031-54-7) 12.3 Sunitinib Malate (CAS 341031-54-7) Production Process 12.4 Sunitinib Malate (CAS 341031-54-7) Industrial Chain 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.2 Sunitinib Malate (CAS 341031-54-7) Typical Distributors 13.3 Sunitinib Malate (CAS 341031-54-7) Typical Customers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Research Process and Data Source 15.3 Disclaimer

List of Tables Table 1. Global Sunitinib Malate (CAS 341031-54-7) Revenue by Type, (USD Million), 2017 & 2021 & 2028 Table 2. Global Sunitinib Malate (CAS 341031-54-7) Revenue by Application, (USD Million), 2017 & 2021 & 2028 Table 3. Pfizer Sutent Basic Information, Manufacturing Base and Competitors Table 4. Pfizer Sutent Major Business Table 5. Pfizer Sutent Sunitinib Malate (CAS 341031-54-7) Product and Services Table 6. Pfizer Sutent Sunitinib Malate (CAS 341031-54-7) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 7. Topcare pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors Table 8. Topcare pharmaceutical Co., Ltd Major Business Table 9. Topcare pharmaceutical Co., Ltd Sunitinib Malate (CAS 341031-54-7) Product and Services Table 10. Topcare pharmaceutical Co., Ltd Sunitinib Malate (CAS 341031-54-7) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 11. Nanjing First Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors Table 12. Nanjing First Pharmaceutical Co., Ltd. Major Business Table 13. Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate (CAS 341031-54-7) Product and Services Table 14. Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate (CAS 341031-54-7) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 15. J&K Scientific Basic Information, Manufacturing Base and Competitors Table 16. J&K Scientific Major Business Table 17. J&K Scientific Sunitinib Malate (CAS 341031-54-7) Product and Services Table 18. J&K Scientific Sunitinib Malate (CAS 341031-54-7) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 19. Target Molecule Corp. Basic Information, Manufacturing Base and Competitors Table 20. Target Molecule Corp. Major Business Table 21. Target Molecule Corp. Sunitinib Malate (CAS 341031-54-7) Product and Services Table 22. Target Molecule Corp. Sunitinib Malate (CAS 341031-54-7) Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 23. Global Sunitinib Malate (CAS 341031-54-7) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT) Table 24. Global Sunitinib Malate (CAS 341031-54-7) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million) Table 25. Market Position of Manufacturers in Sunitinib Malate (CAS 341031-54-7), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021 Table 26. Global Sunitinib Malate (CAS 341031-54-7) Production Capacity by Company, (MT): 2020 VS 2021 Table 27. Head Office and Sunitinib Malate (CAS 341031-54-7) Production Site of Key Manufacturer Table 28. Sunitinib Malate (CAS 341031-54-7) New Entrant and Capacity Expansion Plans Table 29. Sunitinib Malate (CAS 341031-54-7) Mergers & Acquisitions in the Past Five Years Table 30. Global Sunitinib Malate (CAS 341031-54-7) Sales by Region (2017-2022) & (MT) Table 31. Global Sunitinib Malate (CAS 341031-54-7) Sales by Region (2023-2028) & (MT) Table 32. Global Sunitinib Malate (CAS 341031-54-7) Revenue by Region (2017-2022) & (USD Million) Table 33. Global Sunitinib Malate (CAS 341031-54-7) Revenue by Region (2023-2028) & (USD Million) Table 34. Global Sunitinib Malate (CAS 341031-54-7) Sales by Type (2017-2022) & (MT) Table 35. Global Sunitinib Malate (CAS 341031-54-7) Sales by Type (2023-2028) & (MT) Table 36. Global Sunitinib Malate (CAS 341031-54-7) Revenue by Type (2017-2022) & (USD Million) Table 37. Global Sunitinib Malate (CAS 341031-54-7) Revenue by Type (2023-2028) & (USD Million) Table 38. Global Sunitinib Malate (CAS 341031-54-7) Price by Type (2017-2022) & (USD/Kg) Table 39. Global Sunitinib Malate (CAS 341031-54-7) Price by Type (2023-2028) & (USD/Kg) Table 40. Global Sunitinib Malate (CAS 341031-54-7) Sales by Application (2017-2022) & (MT) Table 41. Global Sunitinib Malate (CAS 341031-54-7) Sales by Application (2023-2028) & (MT) Table 42. Global Sunitinib Malate (CAS 341031-54-7) Revenue by Application (2017-2022) & (USD Million) Table 43. Global Sunitinib Malate (CAS 341031-54-7) Revenue by Application (2023-2028) & (USD Million) Table 44. Global Sunitinib Malate (CAS 341031-54-7) Price by Application (2017-2022) & (USD/Kg) Table 45. Global Sunitinib Malate (CAS 341031-54-7) Price by Application (2023-2028) & (USD/Kg) Table 46. North America Sunitinib Malate (CAS 341031-54-7) Sales by Country (2017-2022) & (MT) Table 47. North America Sunitinib Malate (CAS 341031-54-7) Sales by Country (2023-2028) & (MT) Table 48. North America Sunitinib Malate (CAS 341031-54-7) Revenue by Country (2017-2022) & (USD Million) Table 49. North America Sunitinib Malate (CAS 341031-54-7) Revenue by Country (2023-2028) & (USD Million) Table 50. North America Sunitinib Malate (CAS 341031-54-7) Sales by Type (2017-2022) & (MT) Table 51. North America Sunitinib Malate (CAS 341031-54-7) Sales by Type (2023-2028) & (MT) Table 52. North America Sunitinib Malate (CAS 341031-54-7) Sales by Application (2017-2022) & (MT) Table 53. North America Sunitinib Malate (CAS 341031-54-7) Sales by Application (2023-2028) & (MT) Table 54. Europe Sunitinib Malate (CAS 341031-54-7) Sales by Country (2017-2022) & (MT) Table 55. Europe Sunitinib Malate (CAS 341031-54-7) Sales by Country (2023-2028) & (MT) Table 56. Europe Sunitinib Malate (CAS 341031-54-7) Revenue by Country (2017-2022) & (USD Million) Table 57. Europe Sunitinib Malate (CAS 341031-54-7) Revenue by Country (2023-2028) & (USD Million) Table 58. Europe Sunitinib Malate (CAS 341031-54-7) Sales by Type (2017-2022) & (MT) Table 59. Europe Sunitinib Malate (CAS 341031-54-7) Sales by Type (2023-2028) & (MT) Table 60. Europe Sunitinib Malate (CAS 341031-54-7) Sales by Application (2017-2022) & (MT) Table 61. Europe Sunitinib Malate (CAS 341031-54-7) Sales by Application (2023-2028) & (MT) Table 62. Asia-Pacific Sunitinib Malate (CAS 341031-54-7) Sales by Region (2017-2022) & (MT) Table 63. Asia-Pacific Sunitinib Malate (CAS 341031-54-7) Sales by Region (2023-2028) & (MT) Table 64. Asia-Pacific Sunitinib Malate (CAS 341031-54-7) Revenue by Region (2017-2022) & (USD Million) Table 65. Asia-Pacific Sunitinib Malate (CAS 341031-54-7) Revenue by Region (2023-2028) & (USD Million) Table 66. Asia-Pacific Sunitinib Malate (CAS 341031-54-7) Sales by Type (2017-2022) & (MT) Table 67. Asia-Pacific Sunitinib Malate (CAS 341031-54-7) Sales by Type (2023-2028) & (MT) Table 68. Asia-Pacific Sunitinib Malate (CAS 341031-54-7) Sales by Application (2017-2022) & (MT) Table 69. Asia-Pacific Sunitinib Malate (CAS 341031-54-7) Sales by Application (2023-2028) & (MT) Table 70. South America Sunitinib Malate (CAS 341031-54-7) Sales by Country (2017-2022) & (MT) Table 71. South America Sunitinib Malate (CAS 341031-54-7) Sales by Country (2023-2028) & (MT) Table 72. South America Sunitinib Malate (CAS 341031-54-7) Revenue by Country (2017-2022) & (USD Million) Table 73. South America Sunitinib Malate (CAS 341031-54-7) Revenue by Country (2023-2028) & (USD Million) Table 74. South America Sunitinib Malate (CAS 341031-54-7) Sales by Type (2017-2022) & (MT) Table 75. South America Sunitinib Malate (CAS 341031-54-7) Sales by Type (2023-2028) & (MT) Table 76. South America Sunitinib Malate (CAS 341031-54-7) Sales by Application (2017-2022) & (MT) Table 77. South America Sunitinib Malate (CAS 341031-54-7) Sales by Application (2023-2028) & (MT) Table 78. Middle East & Africa Sunitinib Malate (CAS 341031-54-7) Sales by Region (2017-2022) & (MT) Table 79. Middle East & Africa Sunitinib Malate (CAS 341031-54-7) Sales by Region (2023-2028) & (MT) Table 80. Middle East & Africa Sunitinib Malate (CAS 341031-54-7) Revenue by Region (2017-2022) & (USD Million) Table 81. Middle East & Africa Sunitinib Malate (CAS 341031-54-7) Revenue by Region (2023-2028) & (USD Million) Table 82. Middle East & Africa Sunitinib Malate (CAS 341031-54-7) Sales by Type (2017-2022) & (MT) Table 83. Middle East & Africa Sunitinib Malate (CAS 341031-54-7) Sales by Type (2023-2028) & (MT) Table 84. Middle East & Africa Sunitinib Malate (CAS 341031-54-7) Sales by Application (2017-2022) & (MT) Table 85. Middle East & Africa Sunitinib Malate (CAS 341031-54-7) Sales by Application (2023-2028) & (MT) Table 86. Sunitinib Malate (CAS 341031-54-7) Raw Material Table 87. Key Manufacturers of Sunitinib Malate (CAS 341031-54-7) Raw Materials Table 88. Direct Channel Pros & Cons Table 89. Indirect Channel Pros & Cons Table 90. Sunitinib Malate (CAS 341031-54-7) Typical Distributors Table 91. Sunitinib Malate (CAS 341031-54-7) Typical Customers List of Figures Figure 1. Sunitinib Malate (CAS 341031-54-7) Picture Figure 2. Global Sunitinib Malate (CAS 341031-54-7) Revenue Market Share by Type in 2021 Figure 3. Purity Above 99% Figure 4. Purity Above 98% Figure 5. Purity Above 97% Figure 6. Global Sunitinib Malate (CAS 341031-54-7) Revenue Market Share by Application in 2021 Figure 7. Advanced Kidney Cancer Figure 8. GIST (Gastrointestinal Stromal Tumor) Figure 9. Pancreatic Neuroendocrine Tumors Figure 10. Global Sunitinib Malate (CAS 341031-54-7) Revenue, (USD Million) & (MT): 2017 & 2021 & 2028 Figure 11. Global Sunitinib Malate (CAS 341031-54-7) Revenue and Forecast (2017-2028) & (USD Million) Figure 12. Global Sunitinib Malate (CAS 341031-54-7) Sales (2017-2028) & (MT) Figure 13. Global Sunitinib Malate (CAS 341031-54-7) Price (2017-2028) & (USD/Kg) Figure 14. Global Sunitinib Malate (CAS 341031-54-7) Production Capacity (2017-2028) & (MT) Figure 15. Global Sunitinib Malate (CAS 341031-54-7) Production Capacity by Geographic Region: 2022 VS 2028 Figure 16. Sunitinib Malate (CAS 341031-54-7) Market Drivers Figure 17. Sunitinib Malate (CAS 341031-54-7) Market Restraints Figure 18. Sunitinib Malate (CAS 341031-54-7) Market Trends Figure 19. Global Sunitinib Malate (CAS 341031-54-7) Sales Market Share by Manufacturer in 2021 Figure 20. Global Sunitinib Malate (CAS 341031-54-7) Revenue Market Share by Manufacturer in 2021 Figure 21. Sunitinib Malate (CAS 341031-54-7) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021 Figure 22. Top 3 Sunitinib Malate (CAS 341031-54-7) Manufacturer (Revenue) Market Share in 2021 Figure 23. Top 6 Sunitinib Malate (CAS 341031-54-7) Manufacturer (Revenue) Market Share in 2021 Figure 24. Global Sunitinib Malate (CAS 341031-54-7) Sales Market Share by Region (2017-2028) Figure 25. Global Sunitinib Malate (CAS 341031-54-7) Revenue Market Share by Region (2017-2028) Figure 26. North America Sunitinib Malate (CAS 341031-54-7) Revenue (2017-2028) & (USD Million) Figure 27. Europe Sunitinib Malate (CAS 341031-54-7) Revenue (2017-2028) & (USD Million) Figure 28. Asia-Pacific Sunitinib Malate (CAS 341031-54-7) Revenue (2017-2028) & (USD Million) Figure 29. South America Sunitinib Malate (CAS 341031-54-7) Revenue (2017-2028) & (USD Million) Figure 30. Middle East & Africa Sunitinib Malate (CAS 341031-54-7) Revenue (2017-2028) & (USD Million) Figure 31. Global Sunitinib Malate (CAS 341031-54-7) Sales Market Share by Type (2017-2028) Figure 32. Global Sunitinib Malate (CAS 341031-54-7) Revenue Market Share by Type (2017-2028) Figure 33. Global Sunitinib Malate (CAS 341031-54-7) Price by Type (2017-2028) & (USD/Kg) Figure 34. Global Sunitinib Malate (CAS 341031-54-7) Sales Market Share by Application (2017-2028) Figure 35. Global Sunitinib Malate (CAS 341031-54-7) Revenue Market Share by Application (2017-2028) Figure 36. Global Sunitinib Malate (CAS 341031-54-7) Price by Application (2017-2028) & (USD/Kg) Figure 37. North America Sunitinib Malate (CAS 341031-54-7) Sales Market Share by Type (2017-2028) Figure 38. North America Sunitinib Malate (CAS 341031-54-7) Sales Market Share by Application (2017-2028) Figure 39. North America Sunitinib Malate (CAS 341031-54-7) Sales Market Share by Country (2017-2028) Figure 40. North America Sunitinib Malate (CAS 341031-54-7) Revenue Market Share by Country (2017-2028) Figure 41. United States Sunitinib Malate (CAS 341031-54-7) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 42. Canada Sunitinib Malate (CAS 341031-54-7) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 43. Mexico Sunitinib Malate (CAS 341031-54-7) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 44. Europe Sunitinib Malate (CAS 341031-54-7) Sales Market Share by Type (2017-2028) Figure 45. Europe Sunitinib Malate (CAS 341031-54-7) Sales Market Share by Application (2017-2028) Figure 46. Europe Sunitinib Malate (CAS 341031-54-7) Sales Market Share by Country (2017-2028) Figure 47. Europe Sunitinib Malate (CAS 341031-54-7) Revenue Market Share by Country (2017-2028) Figure 48. Germany Sunitinib Malate (CAS 341031-54-7) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 49. France Sunitinib Malate (CAS 341031-54-7) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 50. United Kingdom Sunitinib Malate (CAS 341031-54-7) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 51. Russia Sunitinib Malate (CAS 341031-54-7) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 52. Italy Sunitinib Malate (CAS 341031-54-7) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 53. Asia-Pacific Sunitinib Malate (CAS 341031-54-7) Sales Market Share by Region (2017-2028) Figure 54. Asia-Pacific Sunitinib Malate (CAS 341031-54-7) Sales Market Share by Application (2017-2028) Figure 55. Asia-Pacific Sunitinib Malate (CAS 341031-54-7) Sales Market Share by Region (2017-2028) Figure 56. Asia-Pacific Sunitinib Malate (CAS 341031-54-7) Revenue Market Share by Region (2017-2028) Figure 57. China Sunitinib Malate (CAS 341031-54-7) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 58. Japan Sunitinib Malate (CAS 341031-54-7) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 59. Korea Sunitinib Malate (CAS 341031-54-7) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 60. India Sunitinib Malate (CAS 341031-54-7) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 61. Southeast Asia Sunitinib Malate (CAS 341031-54-7) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 62. Australia Sunitinib Malate (CAS 341031-54-7) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 63. South America Sunitinib Malate (CAS 341031-54-7) Sales Market Share by Type (2017-2028) Figure 64. South America Sunitinib Malate (CAS 341031-54-7) Sales Market Share by Application (2017-2028) Figure 65. South America Sunitinib Malate (CAS 341031-54-7) Sales Market Share by Country (2017-2028) Figure 66. South America Sunitinib Malate (CAS 341031-54-7) Revenue Market Share by Country (2017-2028) Figure 67. Brazil Sunitinib Malate (CAS 341031-54-7) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 68. Argentina Sunitinib Malate (CAS 341031-54-7) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 69. Middle East & Africa Sunitinib Malate (CAS 341031-54-7) Sales Market Share by Type (2017-2028) Figure 70. Middle East & Africa Sunitinib Malate (CAS 341031-54-7) Sales Market Share by Application (2017-2028) Figure 71. Middle East & Africa Sunitinib Malate (CAS 341031-54-7) Sales Market Share by Region (2017-2028) Figure 72. Middle East & Africa Sunitinib Malate (CAS 341031-54-7) Revenue Market Share by Region (2017-2028) Figure 73. Turkey Sunitinib Malate (CAS 341031-54-7) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 74. Egypt Sunitinib Malate (CAS 341031-54-7) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 75. Saudi Arabia Sunitinib Malate (CAS 341031-54-7) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 76. South Africa Sunitinib Malate (CAS 341031-54-7) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 77. Manufacturing Cost Structure Analysis of Sunitinib Malate (CAS 341031-54-7) in 2021 Figure 78. Manufacturing Process Analysis of Sunitinib Malate (CAS 341031-54-7) Figure 79. Sunitinib Malate (CAS 341031-54-7) Industrial Chain Figure 80. Sales Channel: Direct Channel vs Indirect Channel Figure 81. Methodology Figure 82. Research Process and Data Source

Pfizer Sutent Topcare pharmaceutical Co., Ltd Nanjing First Pharmaceutical Co., Ltd. J&K Scientific Target Molecule Corp.